In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by Travis Engelhaupt, digital experience director, and Naomi Lovell, project manager. Together, they discuss website trends and best practices.

Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

The following list includes updates posted to mayocliniclabs.com during the month of July

Top highlights include: Mayo Clinic expert discusses what it will take to reduce widespread transmission, herd immunity discussion with Dr. Bill Morice, skin care tips, and COVID-19 back-to-school checklist.

In the last decade or so, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays. This incredible technology has facilitated the rapid and high-throughput evaluation of many genes (hundreds of thousands of DNA strands) all at once.

This week’s research roundup features a study the exploration of the transcriptomic differences between patients with hypertrophic cardiomyopathy (HCM) and controls.

Top highlights include: test pooling and precautions from Dr. Bill Morice, radiology technologists uses slow times to train to help with department's AI projects, and a COVID-19 update with Dr. Greg Poland.

This week’s research roundup features a study on cardiac troponin for the diagnosis and risk-stratification of myocardial injury in patients with COVID-19.

Top highlights include: how to understand contact tracing, supply chain management during COVID-19, infections of the virus in children, and the benefits of wearing a mask.

In June 2020, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

This week’s research roundup features a study on neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed opioid pain-relieving medication.

Top highlights include: how to stay on track with medications, understanding the difference between antibody and diagnostic tests, news skills on Amazon's Alexa, and testing sites in Rochester, MN converge.

A new episode of "Discussions with the Directors" is available on the topic of paraneoplastic testing - when is it appropriate and what is the way ahead. Listen Now!